{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:15:30Z","timestamp":1794863730204,"version":"4.9.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>As cancer cell specific rewiring of metabolic networks creates potential therapeutic opportunities, we conducted a synthetic lethal screen utilizing inhibitors of metabolic pathways. Simultaneous administration of (R)-GNE-140 and BMS-986205 (Linrodostat) preferentially halted proliferation of ovarian cancer cells, but not of their non-oncogenically transformed progenitor cells. While (R)-GNE-140 inhibits lactate dehydrogenase (LDH)A\/B and thus effective glycolysis, BMS-986205, in addition to its known inhibitory activity on Indoleamine 2,3-dioxygenase (IDO1), also restricts oxidative phosphorylation (OXPHOS), as revealed here. BMS-986205, which is being tested in multiple Phase III clinical trials, inhibits the ubiquinone reduction site of respiratory complex I and thus compromises mitochondrial ATP production. The energetic catastrophe caused by simultaneous interference with glycolysis and OXPHOS resulted in either cell death or the induction of senescence in tumor cells, with the latter being eliminated by senolytics. The frequent synergy observed with combined inhibitor treatment was comprehensively confirmed through testing on tumor cell lines from the DepMap panel and on human colorectal cancer organoids. These experiments revealed highly synergistic activity of the compounds in a third of the tested tumor cell lines, correlating with alterations in genes with known roles in metabolic regulation and demonstrating the therapeutic potential of metabolic intervention.<\/jats:p>","DOI":"10.1038\/s41418-025-01532-5","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:46:30Z","timestamp":1750668390000},"page":"2239-2256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4708-2678","authenticated-orcid":false,"given":"Jan","family":"Dreute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1014-7290","authenticated-orcid":false,"given":"Julia","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6765-6958","authenticated-orcid":false,"given":"Jonas","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2759-6006","authenticated-orcid":false,"given":"David","family":"van den Borre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3573-906X","authenticated-orcid":false,"given":"Maximilian","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6872-9082","authenticated-orcid":false,"given":"Marek","family":"Bartkuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-2020","authenticated-orcid":false,"given":"Vanessa M.","family":"Beutgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4434-3158","authenticated-orcid":false,"given":"Benardina","family":"Ndreshkjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3015-5850","authenticated-orcid":false,"given":"Johannes","family":"Graumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5691-575X","authenticated-orcid":false,"given":"Michael","family":"Huck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0064-3367","authenticated-orcid":false,"given":"Stephan","family":"Klatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9036-4099","authenticated-orcid":false,"given":"Chloe","family":"Leff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-5366","authenticated-orcid":false,"given":"Henner F.","family":"Farin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-6807","authenticated-orcid":false,"given":"Roland","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-7826","authenticated-orcid":false,"given":"Thorsten","family":"Stiewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3880-1968","authenticated-orcid":false,"given":"Julia","family":"Teply-Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-9647","authenticated-orcid":false,"given":"Jochen","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-3794","authenticated-orcid":false,"given":"Alfredo","family":"Cabrera-Orefice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6984-7192","authenticated-orcid":false,"given":"M. Lienhard","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"1532_CR1","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2:e1600200.","journal-title":"Sci Adv"},{"key":"1532_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd4145","volume":"12","author":"L Galluzzi","year":"2013","unstructured":"Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G. Metabolic targets for cancer therapy. Nat Rev Drug Discov. 2013;12:829\u201346.","journal-title":"Nat Rev Drug Discov"},{"key":"1532_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tcb.2020.09.010","volume":"31","author":"SC Baksh","year":"2021","unstructured":"Baksh SC, Finley LWS. Metabolic coordination of cell fate by alpha-ketoglutarate-dependent dioxygenases. Trends Cell Biol. 2021;31:24\u201336.","journal-title":"Trends Cell Biol"},{"key":"1532_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.molcel.2013.05.003","volume":"51","author":"LB Sullivan","year":"2013","unstructured":"Sullivan LB, Martinez-Garcia E, Nguyen H, Mullen AR, Dufour E, Sudarshan S, et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol Cell. 2013;51:236\u201348.","journal-title":"Mol Cell"},{"key":"1532_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462:739\u201344.","journal-title":"Nature"},{"key":"1532_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011;43:869\u201374.","journal-title":"Nat Genet"},{"key":"1532_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476:346\u201350.","journal-title":"Nature"},{"key":"1532_CR8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2015.09.025","volume":"22","author":"AJ Bott","year":"2015","unstructured":"Bott AJ, Peng IC, Fan Y, Faubert B, Zhao L, Li J, et al. Oncogenic myc induces expression of glutamine synthetase through promoter demethylation. Cell Metab. 2015;22:1068\u201377.","journal-title":"Cell Metab"},{"key":"1532_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012;149:656\u201370.","journal-title":"Cell"},{"key":"1532_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:519\u201330.","journal-title":"J Gen Physiol"},{"key":"1532_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","volume":"23","author":"J Schwenck","year":"2023","unstructured":"Schwenck J, Sonanini D, Cotton JM, Rammensee HG, la Fougere C, Zender L, et al. Advances in PET imaging of cancer. Nat Rev Cancer. 2023;23:474\u201390.","journal-title":"Nat Rev Cancer"},{"key":"1532_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38009-3","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xu F, Yao J, Mao C, Zhu M, Qian M, et al. Single-cell metabolic fingerprints discover a cluster of circulating tumor cells with distinct metastatic potential. Nat Commun. 2023;14:2485.","journal-title":"Nat Commun"},{"key":"1532_CR13","doi-asserted-by":"crossref","unstructured":"Almeida-Nunes DL, Silvestre R, Dinis-Oliveira RJ, Ricardo S. Enhancing immunotherapy in ovarian cancer: the emerging role of metformin and statins. Int J Mol Sci 2023;25:323.","DOI":"10.3390\/ijms25010323"},{"key":"1532_CR14","doi-asserted-by":"publisher","first-page":"1256747","DOI":"10.3389\/fonc.2023.1256747","volume":"13","author":"X Jia","year":"2023","unstructured":"Jia X, Lu Y, Xu Z, Mu Q. Impact of statin use on breast cancer recurrence and mortality before and after diagnosis: a systematic review and meta-analysis. Front Oncol. 2023;13:1256747.","journal-title":"Front Oncol"},{"key":"1532_CR15","doi-asserted-by":"crossref","unstructured":"Obrist F, Michels J, Durand S, Chery A, Pol J, Levesque S, et al. Metabolic vulnerability of cisplatin-resistant cancers. EMBO J 2018;37:e98597.","DOI":"10.15252\/embj.201798597"},{"key":"1532_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18504-7","volume":"11","author":"N Gremke","year":"2020","unstructured":"Gremke N, Polo P, Dort A, Schneikert J, Elmshauser S, Brehm C, et al. mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability. Nat Commun. 2020;11:4684.","journal-title":"Nat Commun"},{"key":"1532_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semradonc.2009.09.002","volume":"20","author":"AK Ng","year":"2010","unstructured":"Ng AK, Kenney LB, Gilbert ES, Travis LB. Secondary malignancies across the age spectrum. Semin Radiat Oncol. 2010;20:67\u201378.","journal-title":"Semin Radiat Oncol"},{"key":"1532_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30:36\u201350.","journal-title":"Cell Metab"},{"key":"1532_CR19","doi-asserted-by":"publisher","first-page":"902117","DOI":"10.3389\/fped.2022.902117","volume":"10","author":"L Maese","year":"2022","unstructured":"Maese L, Rau RE. Current use of asparaginase in acute lymphoblastic leukemia\/lymphoblastic lymphoma. Front Pediatr. 2022;10:902117.","journal-title":"Front Pediatr"},{"key":"1532_CR20","doi-asserted-by":"publisher","first-page":"102461","DOI":"10.1016\/j.ctrv.2022.102461","volume":"110","author":"Y Fujiwara","year":"2022","unstructured":"Fujiwara Y, Kato S, Nesline MK, Conroy JM, DePietro P, Pabla S, et al. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. Cancer Treat Rev. 2022;110:102461.","journal-title":"Cancer Treat Rev"},{"key":"1532_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1158\/0008-5472.CAN-11-2178","volume":"72","author":"H Kulbe","year":"2012","unstructured":"Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG, et al. A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res. 2012;72:66\u201375.","journal-title":"Cancer Res"},{"key":"1532_CR22","first-page":"284","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics. CA Cancer J Clin. 2018;68:284\u201396.","journal-title":"CA Cancer J Clin"},{"key":"1532_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14:9\u201332.","journal-title":"Cancer Biol Med"},{"key":"1532_CR24","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/s41588-023-01557-x","volume":"55","author":"CJ Ryan","year":"2023","unstructured":"Ryan CJ, Devakumar LPS, Pettitt SJ, Lord CJ. Complex synthetic lethality in cancer. Nat Genet. 2023;55:2039\u201348.","journal-title":"Nat Genet"},{"key":"1532_CR25","doi-asserted-by":"crossref","unstructured":"Jin H, Wang S, Zaal EA, Wang C, Wu H, Bosma A, et al. A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer. Elife 2020;9:e56749.","DOI":"10.7554\/eLife.56749"},{"key":"1532_CR26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ijc.29010","volume":"136","author":"C Ke","year":"2015","unstructured":"Ke C, Hou Y, Zhang H, Fan L, Ge T, Guo B, et al. Large-scale profiling of metabolic dysregulation in ovarian cancer. Int J Cancer. 2015;136:516\u201326.","journal-title":"Int J Cancer"},{"key":"1532_CR27","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498\u2013503.","journal-title":"Nat Med"},{"key":"1532_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N.","year":"2011","unstructured":"Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315.","journal-title":"Nature"},{"key":"1532_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun. 2017;8:1093.","journal-title":"Nat Commun"},{"key":"1532_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"1532_CR31","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1532_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nchembio.2143","volume":"12","author":"A Boudreau","year":"2016","unstructured":"Boudreau A, Purkey HE, Hitz A, Robarge K, Peterson D, Labadie S, et al. Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nat Chem Biol. 2016;12:779\u201386.","journal-title":"Nat Chem Biol"},{"key":"1532_CR33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1021\/acsmedchemlett.0c00668","volume":"12","author":"EC Cherney","year":"2021","unstructured":"Cherney EC, Zhang L, Nara S, Zhu X, Gullo-Brown J, Maley D, et al. Discovery and preclinical evaluation of BMS-986242, a potent, selective inhibitor of indoleamine-2,3-dioxygenase 1. ACS Med Chem Lett. 2021;12:288\u201394.","journal-title":"ACS Med Chem Lett"},{"key":"1532_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jane-Valbuena J, Kryukov GV, Lo CC, McDonald ER, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"1532_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12494-x","volume":"10","author":"R Caeser","year":"2019","unstructured":"Caeser R, Di Re M, Krupka JA, Gao J, Lara-Chica M, Dias JML, et al. Genetic modification of primary human B cells to model high-grade lymphoma. Nat Commun. 2019;10:4543.","journal-title":"Nat Commun"},{"key":"1532_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep19103","volume":"6","author":"M Zanoni","year":"2016","unstructured":"Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 2016;6:19103.","journal-title":"Sci Rep"},{"key":"1532_CR37","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","volume":"13","author":"HF Farin","year":"2023","unstructured":"Farin HF, Mosa MH, Ndreshkjana B, Grebbin BM, Ritter B, Menche C, et al. Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses. Cancer Discov. 2023;13:2192\u2013211.","journal-title":"Cancer Discov"},{"key":"1532_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk A, Janiszewska M, Polyak K. Intratumor heterogeneity: the rosetta stone of therapy resistance. Cancer Cell. 2020;37:471\u201384.","journal-title":"Cancer Cell"},{"key":"1532_CR39","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853\u201368.","journal-title":"PLoS Biol"},{"key":"1532_CR40","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/febs.16381","volume":"290","author":"M Takasugi","year":"2023","unstructured":"Takasugi M, Yoshida Y, Hara E, Ohtani N. The role of cellular senescence and SASP in tumour microenvironment. FEBS J. 2023;290:1348\u201361.","journal-title":"FEBS J"},{"key":"1532_CR41","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1016\/j.molcel.2022.07.017","volume":"82","author":"MC Lanz","year":"2022","unstructured":"Lanz MC, Zatulovskiy E, Swaffer MP, Zhang L, Ilerten I, Zhang S, et al. Increasing cell size remodels the proteome and promotes senescence. Mol Cell. 2022;82:3255\u201369.e3258.","journal-title":"Mol Cell"},{"key":"1532_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018;28:436\u201353.","journal-title":"Trends Cell Biol"},{"key":"1532_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/978-1-62703-239-1_27","volume":"965","author":"C Correia-Melo","year":"2013","unstructured":"Correia-Melo C, Jurk D, Passos JF. Robust multiparametric assessment of cellular senescence. Methods Mol Biol. 2013;965:409\u201319.","journal-title":"Methods Mol Biol"},{"key":"1532_CR44","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1091\/mbc.e11-10-0884","volume":"23","author":"A Freund","year":"2012","unstructured":"Freund A, Laberge RM, Demaria M, Campisi J. Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell. 2012;23:2066\u201375.","journal-title":"Mol Biol Cell"},{"key":"1532_CR45","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt CA, Wang B, Demaria M. Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"1532_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","volume":"18","author":"W Huang","year":"2022","unstructured":"Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO. Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol. 2022;18:611\u201327.","journal-title":"Nat Rev Nephrol"},{"key":"1532_CR47","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2023","unstructured":"Zhang L, Pitcher LE, Prahalad V, Niedernhofer LJ, Robbins PD. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J. 2023;290:1362\u201383.","journal-title":"FEBS J"},{"key":"1532_CR48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nchembio.332","volume":"6","author":"J Li","year":"2010","unstructured":"Li J, Rix U, Fang B, Bai Y, Edwards A, Colinge J, et al. A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol. 2010;6:291\u20139.","journal-title":"Nat Chem Biol"},{"key":"1532_CR49","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","volume":"163","author":"GS Shadel","year":"2015","unstructured":"Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis. Cell. 2015;163:560\u20139.","journal-title":"Cell"},{"key":"1532_CR50","doi-asserted-by":"crossref","unstructured":"Pathria G, Scott DA, Feng Y, Sang Lee J, Fujita Y, Zhang G, et al. Targeting the warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. EMBO J 2018;37:e99735.","DOI":"10.15252\/embj.201899735"},{"key":"1532_CR51","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1074\/jbc.M115.680553","volume":"291","author":"K Shinzawa-Itoh","year":"2016","unstructured":"Shinzawa-Itoh K, Shimomura H, Yanagisawa S, Shimada S, Takahashi R, Oosaki M, et al. Purification of active respiratory supercomplex from bovine heart mitochondria enables functional studies. J Biol Chem. 2016;291:4178\u201384.","journal-title":"J Biol Chem"},{"key":"1532_CR52","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nprot.2012.058","volume":"7","author":"M Spinazzi","year":"2012","unstructured":"Spinazzi M, Casarin A, Pertegato V, Salviati L, Angelini C. Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc. 2012;7:1235\u201346.","journal-title":"Nat Protoc"},{"key":"1532_CR53","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.molcel.2021.03.031","volume":"81","author":"R B\u00f6hm","year":"2021","unstructured":"B\u00f6hm R, Imseng S, Jakob RP, Hall MN, Maier T, Hiller S. The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1. Mol Cell. 2021;81:2403\u201316.e5.","journal-title":"Mol Cell"},{"key":"1532_CR54","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","volume":"21","author":"F Pietrocola","year":"2015","unstructured":"Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 2015;21:805\u201321.","journal-title":"Cell Metab"},{"key":"1532_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38538-2","volume":"9","author":"S Lee","year":"2019","unstructured":"Lee S. The genetic and epigenetic association of LDL Receptor Related Protein 1B (LRP1B) gene with childhood obesity. Sci Rep. 2019;9:1815.","journal-title":"Sci Rep"},{"key":"1532_CR56","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1158\/0008-5472.CAN-20-1323","volume":"81","author":"LY Cai","year":"2021","unstructured":"Cai LY, Chen SJ, Xiao SH, Sun QJ, Ding CH, Zheng BN, et al. Targeting p300\/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism. Cancer Res. 2021;81:860\u201372.","journal-title":"Cancer Res"},{"key":"1532_CR57","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1158\/2159-8290.CD-20-1114","volume":"11","author":"AC Mandigo","year":"2021","unstructured":"Mandigo AC, Yuan W, Xu K, Gallagher P, Pang A, Guan YF, et al. RB\/E2F1 as a master regulator of cancer cell metabolism in advanced disease. Cancer Discov. 2021;11:2334\u201353.","journal-title":"Cancer Discov"},{"key":"1532_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.abb.2014.11.008","volume":"575","author":"J Chen","year":"2015","unstructured":"Chen J, Lan T, Zhang W, Dong L, Kang N, Fu M, et al. Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K\/AKT and Stat3 pathways. Arch Biochem Biophys. 2015;575:38\u201345.","journal-title":"Arch Biochem Biophys"},{"key":"1532_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103627","volume":"73","author":"ZH Wang","year":"2021","unstructured":"Wang ZH, Peng WB, Zhang P, Yang XP, Zhou Q. Lactate in the tumour microenvironment: from immune modulation to therapy. EBioMedicine. 2021;73:103627.","journal-title":"EBioMedicine"},{"key":"1532_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48397-9","volume":"15","author":"E Chen","year":"2024","unstructured":"Chen E, Wu J, Huang J, Zhu W, Sun H, Wang X, et al. FLI1 promotes IFN-gamma-induced kynurenine production to impair anti-tumor immunity. Nat Commun. 2024;15:4590.","journal-title":"Nat Commun"},{"key":"1532_CR61","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1021\/acs.oprd.1c00142","volume":"25","author":"RY Nimje","year":"2021","unstructured":"Nimje RY, Kuppusamy P, Krishnamoorthy S, Shanmugam Y, Ramasamy D, Manoharan H, et al. Development of a Stereoselective and Scalable Synthesis for the Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor, BMT-297376; N-((R)-1-((cis)-4-(3-(Difluoromethyl)-2-methoxypyridin-4-yl)cyclohexyl)propyl)-6-methoxynicotinamide. Organic Process Res Devel. 2021;25:1680\u20139.","journal-title":"Organic Process Res Devel"},{"key":"1532_CR62","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/jnc.13090","volume":"133","author":"S Deheshi","year":"2015","unstructured":"Deheshi S, Dabiri B, Fan S, Tsang M, Rintoul GL. Changes in mitochondrial morphology induced by calcium or rotenone in primary astrocytes occur predominantly through ros-mediated remodeling. J Neurochem. 2015;133:684\u201399.","journal-title":"J Neurochem"},{"key":"1532_CR63","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M210432200","volume":"278","author":"N Li","year":"2003","unstructured":"Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 2003;278:8516\u201325.","journal-title":"J Biol Chem"},{"key":"1532_CR64","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-05-4006","volume":"66","author":"M Braig","year":"2006","unstructured":"Braig M, Schmitt CA. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res. 2006;66:2881\u20134.","journal-title":"Cancer Res"},{"key":"1532_CR65","doi-asserted-by":"crossref","unstructured":"Miwa S, Kashyap S, Chini E, von Zglinicki T. Mitochondrial dysfunction in cell senescence and aging. J Clin Invest 2022;132:e158447.","DOI":"10.1172\/JCI158447"},{"key":"1532_CR66","doi-asserted-by":"publisher","first-page":"30107","DOI":"10.1074\/jbc.M705325200","volume":"282","author":"EL Greer","year":"2007","unstructured":"Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem. 2007;282:30107\u201319.","journal-title":"J Biol Chem"},{"key":"1532_CR67","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1126\/science.1068712","volume":"296","author":"H Tran","year":"2002","unstructured":"Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ Jr, DiStefano PS, et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science. 2002;296:530\u20134.","journal-title":"Science"},{"key":"1532_CR68","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0005-2736(86)90406-2","volume":"861","author":"E Goormaghtigh","year":"1986","unstructured":"Goormaghtigh E, Huart P, Brasseur R, Ruysschaert JM. Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives. Biochim Biophys Acta. 1986;861:83\u201394.","journal-title":"Biochim Biophys Acta"},{"key":"1532_CR69","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1042\/bj2590181","volume":"259","author":"O Marcillat","year":"1989","unstructured":"Marcillat O, Zhang Y, Davies KJ. Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin. Biochem J. 1989;259:181\u20139.","journal-title":"Biochem J"},{"key":"1532_CR70","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1158\/1078-0432.CCR-06-1037","volume":"12","author":"Z Yang","year":"2006","unstructured":"Yang Z, Schumaker LM, Egorin MJ, Zuhowski EG, Guo Z, Cullen KJ. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin Cancer Res. 2006;12:5817\u201325.","journal-title":"Clin Cancer Res"},{"key":"1532_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2081-4","volume":"10","author":"M Kleih","year":"2019","unstructured":"Kleih M, Bopple K, Dong M, Gaissler A, Heine S, Olayioye MA, et al. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis. 2019;10:851.","journal-title":"Cell Death Dis"},{"key":"1532_CR72","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1124\/mol.63.1.224","volume":"63","author":"B Notario","year":"2003","unstructured":"Notario B, Zamora M, Vinas O, Mampel T. All-trans-retinoic acid binds to and inhibits adenine nucleotide translocase and induces mitochondrial permeability transition. Mol Pharmacol. 2003;63:224\u201331.","journal-title":"Mol Pharmacol"},{"key":"1532_CR73","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd3137","volume":"9","author":"S Fulda","year":"2010","unstructured":"Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov. 2010;9:447\u201364.","journal-title":"Nat Rev Drug Discov"},{"key":"1532_CR74","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73:354\u201363.e3.","journal-title":"Mol Cell"},{"key":"1532_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu S, Wu LL, Yang L, Yang L, Wang J. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023;14:519.","journal-title":"Cell Death Dis"},{"key":"1532_CR76","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41556-018-0133-0","volume":"20","author":"V Eisner","year":"2018","unstructured":"Eisner V, Picard M, Hajnoczky G. Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat Cell Biol. 2018;20:755\u201365.","journal-title":"Nat Cell Biol"},{"key":"1532_CR77","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1126\/science.1156906","volume":"320","author":"K Ishikawa","year":"2008","unstructured":"Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008;320:661\u20134.","journal-title":"Science"},{"key":"1532_CR78","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1074\/jbc.275.1.223","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem. 2000;275:223\u20138.","journal-title":"J Biol Chem"},{"key":"1532_CR79","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. 2000;348:607\u201314.","journal-title":"Biochem J"},{"key":"1532_CR80","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1126\/science.ade3332","volume":"379","author":"HR Bridges","year":"2023","unstructured":"Bridges HR, Blaza JN, Yin Z, Chung I, Pollak MN, Hirst J. Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides. Science. 2023;379:351\u20137.","journal-title":"Science"},{"key":"1532_CR81","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1182\/blood-2005-04-1622","volume":"106","author":"R van Wijk","year":"2005","unstructured":"van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood. 2005;106:4034\u201342.","journal-title":"Blood"},{"key":"1532_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12317","volume":"7","author":"JK Ehinger","year":"2016","unstructured":"Ehinger JK, Piel S, Ford R, Karlsson M, Sjovall F, Frostner EA, et al. Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency. Nat Commun. 2016;7:12317.","journal-title":"Nat Commun"},{"key":"1532_CR83","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","volume":"33","author":"L Shi","year":"2015","unstructured":"Shi L, Tu BP. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr Opin Cell Biol. 2015;33:125\u201331.","journal-title":"Curr Opin Cell Biol"},{"key":"1532_CR84","doi-asserted-by":"crossref","unstructured":"Pungsrinont T, Kallenbach J, Baniahmad A. Role of PI3K-AKT-mTOR pathway as a pro-survival signaling and resistance-mediating mechanism to therapy of prostate cancer. Int J Mol Sci 2021;22:11088.","DOI":"10.3390\/ijms222011088"},{"key":"1532_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.628690","volume":"12","author":"C Dong","year":"2021","unstructured":"Dong C, Wu J, Chen Y, Nie J, Chen C. Activation of PI3K\/AKT\/mTOR Pathway Causes Drug Resistance in Breast Cancer. Front Pharmacol. 2021;12:628690.","journal-title":"Front Pharmacol"},{"key":"1532_CR86","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.addr.2011.02.002","volume":"63","author":"R Mahato","year":"2011","unstructured":"Mahato R, Tai W, Cheng K. Prodrugs for improving tumor targetability and efficiency. Adv Drug Deliv Rev. 2011;63:659\u201370.","journal-title":"Adv Drug Deliv Rev"},{"key":"1532_CR87","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","volume":"6","author":"MT Manzari","year":"2021","unstructured":"Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA. Targeted drug delivery strategies for precision medicines. Nat Rev Mater. 2021;6:351\u201370.","journal-title":"Nat Rev Mater"},{"key":"1532_CR88","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/nprot.2012.097","volume":"7","author":"AM Karst","year":"2012","unstructured":"Karst AM, Drapkin R. Primary culture and immortalization of human fallopian tube secretory epithelial cells. Nat Protoc. 2012;7:1755\u201364.","journal-title":"Nat Protoc"},{"key":"1532_CR89","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/s41596-021-00506-4","volume":"16","author":"R Caeser","year":"2021","unstructured":"Caeser R, Gao J, Di Re M, Gong C, Hodson DJ. Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells. Nat Protoc. 2021;16:2499\u2013519.","journal-title":"Nat Protoc"},{"key":"1532_CR90","doi-asserted-by":"crossref","unstructured":"Schnalzger TE, de Groot MH, Zhang C, Mosa MH, Michels BE, Roder J, et al. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids. EMBO J 2019;38:e100928.","DOI":"10.15252\/embj.2018100928"},{"key":"1532_CR91","doi-asserted-by":"publisher","first-page":"e0232565","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo A, Torres Figueroa F, Clavijo C, Arbelaez P, Cruz JC, Munoz-Camargo C. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS ONE. 2020;15:e0232565.","journal-title":"PLoS ONE"},{"key":"1532_CR92","doi-asserted-by":"crossref","unstructured":"Feoktistova M, Geserick P, Leverkus M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb Protoc. 2016;2016:pdb.prot087379.","DOI":"10.1101\/pdb.prot087379"},{"key":"1532_CR93","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"1532_CR94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2818.2012.03675.x","volume":"249","author":"H Kirshner","year":"2013","unstructured":"Kirshner H, Aguet F, Sage D, Unser M. 3-D PSF fitting for fluorescence microscopy: implementation and localization application. J Microsc. 2013;249:13\u201325.","journal-title":"J Microsc"},{"key":"1532_CR95","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1152\/ajpendo.00457.2019","volume":"318","author":"A Chaudhry","year":"2020","unstructured":"Chaudhry A, Shi R, Luciani DS. A pipeline for multidimensional confocal analysis of mitochondrial morphology, function, and dynamics in pancreatic beta-cells. Am J Physiol Endocrinol Metab. 2020;318:E87\u2013E101.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1532_CR96","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38:276\u20138.","journal-title":"Nat Biotechnol"},{"key":"1532_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1532_CR98","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"1532_CR99","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19:3292\u2013320.","journal-title":"Nat Protoc"},{"key":"1532_CR100","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139.","journal-title":"Bioinformatics"},{"key":"1532_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1604","volume":"14","author":"F Neuhaus","year":"2024","unstructured":"Neuhaus F, Lieber S, Shinkevich V, Steitz AM, Raifer H, Roth K, et al. Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells. Clin Transl Med. 2024;14:e1604.","journal-title":"Clin Transl Med"},{"key":"1532_CR102","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9:e95192.","journal-title":"PLoS ONE"},{"key":"1532_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J, Bjorkesten J, Assarsson E, Henriksson S, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteomics. 2021;20:100168.","journal-title":"Mol Cell Proteomics"},{"key":"1532_CR104","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/19466315.2018.1437071","volume":"10","author":"Q Liu","year":"2018","unstructured":"Liu Q, Yin X, Languino LR, Altieri DC. Evaluation of drug combination effect using a Bliss independence dose-response surface model. Stat Biopharm Res. 2018;10:112\u201322.","journal-title":"Stat Biopharm Res"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01532-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01532-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01532-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T16:02:17Z","timestamp":1764604937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01532-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":104,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01532-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.02.651820","asserted-by":"object"}]},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the local\/institutional guidelines and European regulations. Tonsil tissue was provided by the department of Otolaryngology, Head and Neck Surgery of the University Hospital of Giessen and Marburg. Tonsil experiments were approved under license AZ37\/20 from the institutional ethics committee of the Justus Liebig University Giessen with prior written informed consent from patients\/parents\/guardians. Human colorectal cancer organoids were provided by the University Cancer Center Frankfurt (UCT). All materials were collected as part of the interdisciplinary Biobank and Database Frankfurt (iBDF), with prior written informed consent from patients. The study received approval from the institutional review board of the UCT and the Ethical Committee at the University Hospital Frankfurt (ethics vote: 4\/09; project number: SGI-10-2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}